Hip replacement lawsuits against the Stryker Corporation alleging that the company’s products were defectively manufactured will continue in court, according to a federal judge in Connecticut. Patients allege that Stryker metal-on-metal hip replacements have failed and caused serious injuries.
Stryker attempted to say that faulty hip replacements were a federal matter since they dealt with the U.S. Food and Drug Administration (FDA). The judge ruled that patient lawsuits were allowed to continue because the approval of the design as well as the manufacturing of the hip implants has been called into question.
The Stryker metal hip implants were approved through the FDA’s 501(k) process, which states the device is so similar to others already on the market that it can bypass significant clinical testing. Many of those other products have since been found to be faulty, leading to several hip replacement lawsuits. Johnson & Johnson recently agreed to a $4 billion settlement involving its metal-on-metal hip replacements.